Pharmaust
2003
FOUNDED
PUBLIC
STATUS
51-60
EMPLOYEES
PAA
STOCK SYMBOL
2
INVESTMENTS
$0.03
SHARE PRICE
(As of Thursday Closing)
Description
Provider of drug discovery and development services. The company is engaged in developing its own drug discovery intellectual property and specialized medicinal and synthetic chemistry services on a contract basis to its clients. It operates in corporate and pharmaceutical segments.
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
ASX
Primary Office
- 1 Freshwater Parade
- Suite 39
- Claremont, Western Australia 6010
- Australia
+61 (08) 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Pharmaust’s full profile, request a free trial.
Pharmaust Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.02 - $0.06 | $5.6M | $0.03 | 1.12M | 199M |
Pharmaust Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2018
|
FY 2018
30-Jun-2018
|
FY 2017
30-Jun-2017
|
FY 2016
30-Jun-2016
|
|---|---|---|---|---|
| Enterprise Value | 5,017 | 4,848 | 5,759 | 5,526 |
| Revenue | 2,224 | 2,151 | 1,470 | |
| EBITDA | (1,868) | (895) | (2,779) | |
| Net Income | (1,953) | (1,013) | (2,861) | |
| Total Assets | 6,140 | 6,298 | 4,673 | |
| Total Debt | 313 | 375 | 454 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Pharmaust Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 00000000000 | 13-Aug-2013 | 000000000000000000 | 00.000 | Other Healthcare Technology Systems | |
| Pela Resources | 10-Sep-2012 | Merger/Acquisition | Precious Metals and Minerals Mining | 000000 0000000 |
Pharmaust Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Robert Bishop | Executive Director |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »